Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 10/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 7/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | F9 | P00740 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27273770 | 1.00 | HSD17B1 (0.37) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL23179323 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL24841517 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL22255764 | 0.99 | ESR1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL24841780 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL24841324 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL23179449 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL24841752 | 0.99 | HSD17B1 (0.36) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL23180316 | 0.98 | HSD17B1 (0.35) | HSD17B1HSD17B2ESR1ESR2S1PR5 | |
| SCHEMBL24842224 | 0.98 | HSD17B1 (0.35) | HSD17B1HSD17B2ESR1ESR2S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC18A2, SLC18A1, MAOA | HSD17B1 617/4885HSD17B2 646/4885ESR1 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.